Literature DB >> 29733693

Blood Neutrophils Are Reprogrammed in Bronchiectasis.

Pallavi Bedi1, Donald J Davidson1, Brian J McHugh1, Adriano G Rossi1, Adam T Hill1,2.   

Abstract

RATIONALE: Excessive neutrophilic airway inflammation is the central feature of bronchiectasis, but little is known about neutrophils in bronchiectasis.
OBJECTIVES: To assess blood neutrophil phenotype in patients with bronchiectasis while stable and during exacerbations.
METHODS: In the clinically stable arm of this study, there were eight healthy volunteers, eight patients with mild bronchiectasis, and eight patients with severe bronchiectasis. In addition, six patients with severe bronchiectasis were compared with six patients with community-acquired pneumonia at the start and end of an exacerbation. We assessed neutrophils for spontaneous apoptosis, cell surface marker expression, degranulation, reactive oxygen species generation, phagocytosis, and killing of Pseudomonas aeruginosa (PAO1). In addition, blood neutrophil function was compared with airway neutrophil function in bronchiectasis.
MEASUREMENTS AND MAIN RESULTS: In stable bronchiectasis, compared with healthy volunteers, blood neutrophils had significantly prolonged viability, delayed apoptosis, increased CD62L shedding, upregulated CD11b expression, increased myeloperoxidase release, and impaired neutrophil phagocytosis and killing of PAO1. Bronchiectatic airway neutrophils had significantly lower bacterial phagocytosis and killing than their matched autologous blood neutrophils. Both blood and airway neutrophil phagocytosis and killing were impaired at the start of an exacerbation and improved following antibiotic treatment. In pneumonia, there was a significant improvement in phagocytosis and killing after treatment with antibiotics. During infections, there was no difference in phagocytosis, but there was significantly increased bacterial killing at the start and end of infection in pneumonia compared with bronchiectasis exacerbations.
CONCLUSIONS: In bronchiectasis stable state, peripheral blood neutrophils are reprogrammed and have prolonged survival. This impairs their functional ability of bacterial phagocytosis and killing, thereby perpetuating the vicious circle in bronchiectasis.

Entities:  

Keywords:  bronchiectasis; infection; inflammation; neutrophils

Mesh:

Substances:

Year:  2018        PMID: 29733693      PMCID: PMC6173062          DOI: 10.1164/rccm.201712-2423OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  30 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  British Thoracic Society guideline for non-CF bronchiectasis.

Authors:  M C Pasteur; D Bilton; A T Hill
Journal:  Thorax       Date:  2010-07       Impact factor: 9.139

Review 3.  Neutrophils and immunity: challenges and opportunities.

Authors:  Carl Nathan
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

4.  Fetal calf serum contains heat-stable nucleases that degrade neutrophil extracellular traps.

Authors:  Maren von Köckritz-Blickwede; Ohn A Chow; Victor Nizet
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

Review 5.  Human neutrophils in the saga of cellular heterogeneity: insights and open questions.

Authors:  Patrizia Scapini; Olivia Marini; Cristina Tecchio; Marco A Cassatella
Journal:  Immunol Rev       Date:  2016-09       Impact factor: 12.988

6.  Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide.

Authors:  C Haslett; L A Guthrie; M M Kopaniak; R B Johnston; P M Henson
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

7.  The chemotactic activity of sputum from patients with bronchiectasis.

Authors:  M Mikami; C G Llewellyn-Jones; D Bayley; S L Hill; R A Stockley
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

8.  Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis.

Authors:  R William Vandivier; Valerie A Fadok; Peter R Hoffmann; Donna L Bratton; Churee Penvari; Kevin K Brown; Joseph D Brain; Frank J Accurso; Peter M Henson
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

9.  Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.

Authors:  James D Chalmers; Maeve P Smith; Brian J McHugh; Cathy Doherty; John R Govan; Adam T Hill
Journal:  Am J Respir Crit Care Med       Date:  2012-06-28       Impact factor: 21.405

10.  Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis.

Authors:  Adriano G Rossi; Deborah A Sawatzky; Annemieke Walker; Carol Ward; Tara A Sheldrake; Nicola A Riley; Alison Caldicott; Magdalena Martinez-Losa; Trevor R Walker; Rodger Duffin; Mohini Gray; Elvira Crescenzi; Morag C Martin; Hugh J Brady; John S Savill; Ian Dransfield; Christopher Haslett
Journal:  Nat Med       Date:  2006-09-03       Impact factor: 53.440

View more
  12 in total

Review 1.  Our evolving view of neutrophils in defining the pathology of chronic lung disease.

Authors:  Kyle T Mincham; Nicoletta Bruno; Aran Singanayagam; Robert J Snelgrove
Journal:  Immunology       Date:  2021-10-04       Impact factor: 7.215

2.  Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes.

Authors:  Xuejie Wang; Casilda Olveira; Rosa Girón; Marta García-Clemente; Luis Máiz; Oriol Sibila; Rafael Golpe; Rosario Menéndez; Juan Rodríguez-López; Concepción Prados; Miguel Angel Martinez-García; Juan Luis Rodriguez; David de la Rosa; Liyun Qin; Xavier Duran; Jordi Garcia-Ojalvo; Esther Barreiro
Journal:  Biomedicines       Date:  2022-04-30

3.  Neutrophils to Lymphocyte Ratio as a Biomarker in Bronchiectasis Exacerbation: A Retrospective Study.

Authors:  Vasiliki E Georgakopoulou; Nikolaos Trakas; Christos Damaskos; Nikolaos Garmpis; Evgenia Karakou; Rea Chatzikyriakou; Panagiota Lambrou; Xanthi Tsiafaki
Journal:  Cureus       Date:  2020-08-13

Review 4.  Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.

Authors:  Meraj A Khan; Zubair Sabz Ali; Neil Sweezey; Hartmut Grasemann; Nades Palaniyar
Journal:  Genes (Basel)       Date:  2019-02-26       Impact factor: 4.096

5.  Stratifying Bronchiectasis: Getting to within a Zone's Throw.

Authors:  Sanjay H Chotirmall
Journal:  Am J Respir Crit Care Med       Date:  2019-10-15       Impact factor: 21.405

Review 6.  Understanding the role of neutrophils in chronic inflammatory airway disease.

Authors:  Alice E Jasper; William J McIver; Elizabeth Sapey; Georgia M Walton
Journal:  F1000Res       Date:  2019-04-26

7.  Effect of OM-85 BV on reducing bronchiectasis exacerbation in Chinese patients: the iPROBE study.

Authors:  Jinming Gao; Lun Li; Nan Jiang; Ying Liao; Lingfei Kong; Yuanlin Song; Jinfu Xu; Jie Cao; Yuping Li; Chengli Que; Roy A Pleasants
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

Review 8.  Proteases, Mucus, and Mucosal Immunity in Chronic Lung Disease.

Authors:  Michael C McKelvey; Ryan Brown; Sinéad Ryan; Marcus A Mall; Sinéad Weldon; Clifford C Taggart
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

9.  A New Bronchiectasis Endophenotype: Immunoallertypes.

Authors:  Pamela J McShane
Journal:  Am J Respir Crit Care Med       Date:  2019-04-01       Impact factor: 21.405

Review 10.  The Spectrum of Non-asthmatic Airway Diseases Contributing to Cough in the Adult.

Authors:  Sidney S Braman; Armeen Poor
Journal:  Curr Otorhinolaryngol Rep       Date:  2019-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.